Endometriosis is a chronic, painful, and often debilitating gynecological condition that affects approximately 190 million women of reproductive age worldwide.…
Read More
Precision Nanomedicine Targeting Immune Dysregulation Shows Preclinical Promise for Endometriosis Using Repurposed Anthelmintic Drug
Endometriosis remains one of the most enigmatic and debilitating gynecological conditions affecting individuals of reproductive age worldwide. Characterized by the…
Read More
Absci Secures $100 Million and Advances AI-Designed Drug Candidate ABS-201 for Endometriosis and Hair Loss
Absci Corporation has successfully closed an underwritten public offering, raising approximately $100 million, a significant financial injection that will fuel…
Read More
Groundbreaking Diagnostic Innovations Promise to Halve Endometriosis Diagnosis Delays, Yet Systemic Hurdles Persist
Endometriosis, a debilitating chronic inflammatory condition affecting an estimated 10% of reproductive-age women globally, continues to be plagued by a…
Read More
